PLUS THERAPEUTICS
Plus Therapeutics is dedicated to developing and delivering innovative cell-based therapies to improve the quality and length of life. It is a global, public company engaged in developing and commercializing stem and regenerative cell therapies for treating cardiovascular disease, reconstructive surgery, and other serious, chronic, and life-threatening conditions. The company's research and development efforts are developing novel formulations and delivery methods for existing drugs to improve t... heir efficacy and reduce side effects. Plus Therapeutics utilizes its proprietary nanotechnology platform to enhance the therapeutic potential of drugs, allowing for targeted delivery to tumors while minimizing damage to healthy tissues. Their pipeline includes potential treatments for various types of cancer, including brain cancer and pancreatic cancer. Plus Therapeutics' pipeline of candidate drug products includes their lead drug product candidates, RNL and DocePLUS, which are being developed in the U.S. by a dedicated and energetic team of biologists, chemists, engineers, physicians, and other professionals.
PLUS THERAPEUTICS
Industry:
Biotechnology Medical Pharmaceutical Therapeutics
Founded:
1996-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.plustherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
737.255.7194
Email Addresses:
[email protected]
Total Funding:
152.25 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro Google Font API WordPress Google Analytics Content Delivery Network Mobile Non Scaleable Content Organization Schema
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Aro Biotherapeutics
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-02-15 | Azaya Therapeutics | Azaya Therapeutics acquired by Plus Therapeutics | N/A |
Investors List
AIGH Capital Management
AIGH Capital Management investment in Post-IPO Equity - Plus Therapeutics
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Plus Therapeutics
Cancer Prevention and Research Institute of Texas
Cancer Prevention and Research Institute of Texas investment in Grant - Plus Therapeutics
GE Capital
GE Capital investment in Post-IPO Debt - Plus Therapeutics
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Plus Therapeutics
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Plus Therapeutics
Official Site Inspections
http://www.plustherapeutics.com Semrush global rank: 5.05 M Semrush visits lastest month: 1.61 K
- Host name: cloudproxy10076.sucuri.net
- IP address: 192.124.249.76
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Plus Therapeutics"
About Us - Plus Therapeutics (PSTV)
We envision innovative radiotherapeutics that become a global standard of care for cancer. Plus Therapeutics (PSTV on Nasdaq) is a U.S. clinical-stage pharmaceutical company, backed by talented executives and a nationwide ā¦See details»
Plus Therapeutics - Wikipedia
Plus Therapeutics, Inc. was formerly known as Cytori Therapeutics, Inc. In 2017, Cytori Therapeutics announced that it had acquired a nanomedicine platform. In 2019, Cytori Therapeutics announced that it had divested its autologous cell therapy assets to Lorem Vascular of Australia and Seijiro Shirahama of Japan. In 2019, Cytori Therapeutics announced that it had changed its focus and name to Plus Therapeutics. In 2020, Plus Therapeutics announced that iā¦See details»
Our Team - Plus Therapeutics (PSTV)
Nicholas Butowski, MD Professor, Neurological Surgery and Director, Translational Research, ā¦See details»
Plus Therapeutics, Inc.: Contact Details and Business Profile
Plustherapeutics.com; yahoo.com; 3 678642XXXX; 678977XXXX; 404944XXXX; View Similar ā¦See details»
Plus Therapeutics, Inc. | LinkedIn
Plus Therapeutics (Nasdaq: PSTV) is a U.S. clinical-stage pharmaceutical company ā¦See details»
Plus Therapeutics - Crunchbase Company Profile & Funding
Plus Therapeutics is dedicated to developing and delivering innovative cell-based therapies to ā¦See details»
Plus Therapeutics, Inc. (PSTV) Company Profile & Overview - Stock ā¦
Dec 24, 2024 4200 Marathon Boulevard, Suite 200 Austin, Texas 78756 United StatesSee details»
PLUS THERAPEUTICS - Company Profile - Tracxn
Aug 17, 2021 PLUS THERAPEUTICS - Provider of therapeutics for multiple cancer ā¦See details»
PLUS THERAPEUTICS, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for PLUS ā¦See details»
Management - Plus Therapeutics (PSTV)
Dr. Marc Hedrick is the President and CEO at Plus Therapeutics, Inc. Previously, Dr. Hedrick ā¦See details»
Plus Therapeutics Inc Company Profile - Overview - GlobalData
Website www.plustherapeutics.com Telephone 1 210 9746900. No of Employees 20. Industry ā¦See details»
Plus Therapeutics Expands Management Team and Reports $3.3M ā¦
AUSTIN, Texas, June 07, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: ā¦See details»
Plus Therapeutics - PitchBook
Plus Therapeutics General Information Description. Plus Therapeutics Inc is a clinical-stage ā¦See details»
Plus Therapeutics Enters Into Master Services Agreement
Mar 23, 2021 More information may be found at PlusTherapeutics.com and ... is a contract ā¦See details»
Plus Therapeutics - Overview, News & Similar companies - ZoomInfo
May 17, 2024 Plus Therapeutics contact info: Phone number: (210) 974-6900 Website: ā¦See details»
Plus Updates Financial and Cash Guidance for 2024 - Plus ā¦
Dec 18, 2023 Plus Receives $3.3M in grant revenue in Q4 2023 Forecasts additional $6.9M ā¦See details»
Board of Directors - Plus Therapeutics (PSTV)
Howard Clowes joined our Board in March 2020. A retired partner after nearly four decades at ā¦See details»
Plus Therapeutics Reports Third Quarter 2023 Financial Results and ...
Oct 31, 2023 New survival data from 15 patients in the Phase 2 ReSPECT-GBM trial of ā¦See details»
Pipeline - Plus Therapeutics (PSTV)
Our radiotherapeutics are designed to deliver radioisotopes, such as Rhenium, into or near a ā¦See details»